CannabisNewsBreaks – Sugarmade, Inc. (SGMD) Sees Significant Jump in Budcars Cannabis Deliveries in March

Sugarmade (OTCQB: SGMD) recently acquired a significant stake in Sacramento-based Budcars Cannabis Delivery Service (http://cnw.fm/jUX5t). An article discussing the company reads, “An agreement announced in February 2020 stipulated that Sugarmade would acquire 40% of Budcars and would be granted an option to purchase an additional 30% stake, ultimately providing SGMD with a controlling interest in the growing delivery service, which serves the greater Sacramento metropolitan area. Budcars delivers a wide range of cannabis products to the metropolitan area, where the population is showing growing acceptance of cannabis usage and delivery and scores above the 50 percentile in terms of cannabis usage per capita. . . . Less than a month after making that initial announcement, Sugarmade followed with a second, even more impressive, statement. Since becoming heavily involved in the day-to-day operational and strategic foundation of Budcars following its initial investment and investor agreement, SGMD had seen a dramatic expansion in overall delivery volume with March deliveries topping February volume by more than 300%.”

To view the full article, visit http://cnw.fm/rFW7V

About Sugarmade Inc.

Sugarmade is a product and branding marketing company investing in operations and technologies with disruptive potential. More information on Sugarmade can be accessed at: www.Sugarmade.com. Sugarmade sees opportunities in business operations that combine the best areas of on-demand consumer distribution with certain areas of synergistic manufacturing and packaging to create a business model that capitalizes on the many changes in the cannabis industry. The company has made agreements with several market participants, which will be announced within Q1 and Q2 of calendar year 2020. The company views these opportunities as very scalable and capable of producing strong revenue growth for the company.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://cnw.fm/SUGAR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW – How to Disinfect Cannabis Packaging Safely

The coronavirus outbreak has put everyone on high alert. With over 3 million confirmed cases and at least 220,000 deaths globally, we should definitely be on guard. The virus spreads primarily through droplets released by an infected person when they sneeze or cough, and governments all over the world have rolled out social distancing measures to help prevent this.

Individuals are to stay indoors unless they absolutely have to, and the businesses that have been allowed to continue operating are required to practice social distancing measures. For the most part, this has involved curbside pickups and home deliveries. Cannabis was one of the industries lucky enough to be deemed essential, and marijuana businesses have also been adhering to these measures.

However, even with proper social distancing and hand washing measures, there have been fears that the virus may spread through contaminated surfaces. According to data from a U.S. National Institute of Health (NIH) study, the virus that causes the coronavirus can survive for up to 24 hours on cardboard and 2-3 days on plastic and stainless steel surfaces.

So how do you make sure your cannabis packages are sterile? Nothing would suck as much as getting infected from a package despite practicing all the other prevention methods.

For starters, try to avoid contact as much as you can. If there is a ‘no contact’ delivery option, go with it. Ideally, the shop and its employees ought to have taken protective measures on their end, you can’t be too cautious. Once the package has been delivered, you’ll have a number of sanitizing options. However, soap and water won’t work as the cannabis will get soaked and suffer damage.

Research has shown that using 62-71% alcohol, 0.5% hydrogen peroxide bleach or household bleach containing 0.1% sodium hypochlorite to disinfect surfaces will deactivate the virus. Make sure you put on gloves before handling the package or the entire process will be moot.

Since the virus survives for a limited time on plastic and steel surfaces, you could also store the package in a cool, dry place for a couple of days. Marijuana doesn’t expire, and any viruses on the packaging will die off after two or three days. You might choose to err on the side of caution and let the package sit for up to a week.

And as always, make sure you wash your hands thoroughly after handling the package.

Experts say these are the same measures that sector players like Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) encourage customers to implement until the government gives the all-clear that the virus has been defeated decisively.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Investing in Cannabis Amid COVID-19 Outbreak May be Wise

The economic fallout from the coronavirus crisis will be massive. With the U.S. already sliding into a recession, experts say it may take years for Americans to recover financially. With the economy in such a state, would it be wise to invest? Wouldn’t it be better to hold onto those funds and see how things play out?

Well, it depends on what you’re investing in. Some stocks, like airline and restaurant stocks, aren’t doing so well right now. A whole lot of industries have been affected by the outbreak, with most of the new unemployment cases concentrated in a certain group of sectors. Cannabis, on the other hand, seems to be holding up.

Most states with legal cannabis programs deemed the cannabis sector essential, meaning cannabis shops and dispensaries could continue operating during the lockdown. Extra measures such as curbside pickups and home deliveries are being approved to make sure their operations remain safe and hygienic. This already gives the cannabis sector an edge over the scores of industries that have been affected by the coronavirus.

However, the fact that cannabis is considered a ‘vice industry’ has made some experts wonder whether it is recession-proof. Historically, vice industries like alcohol have enjoyed increased sales in times of great stress. After most states issued their stay at home orders, cannabis stores reported a spike in demand, with some stating they had lines longer than the ones on the unofficial cannabis holiday 4/20.

The fact that cannabis is medicinal also works in its favor. There are over 200 million registered medical marijuana patients in the country, and with the industry still running, they are still purchasing cannabis. The plant is also a good anti-anxiety drug, and we can agree that this is an extremely stressful time. Both recreational and medical users can use it to help reduce their anxiety and stress.

The coronavirus crisis may even be a blessing in disguise for the cannabis industry. The fact that most states with legal cannabis have deemed it essential has proved that the industry is vital. Hundreds of thousands of employees and millions of patients rely on it, after all. On top of that, it can provide much-needed tax revenue.

The state of Illinois, for instance, has tapped into an emergency relief fund that was funded by cannabis sales taxes to help cushion rural pharmacies during the crisis. This proves just how valuable a legal cannabis market can be, making it an attractive option for investment.

Analysts therefore predict that investors who enter the industry now may reap big in future when the industry players, such as Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), soar even higher in the years to come.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Cannabis Global, Inc. (MCTC) Announces Cannabinoid Sciences Research Breakthrough Unveiled by “Project Varin”

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, today announced a research breakthrough in the field of cannabinoid sciences resulting from the company’s “Project Varin,” which began earlier this year. According to the update, the research program has yielded a new tetrahydrocannabivarin (“THC-V”) delivery system providing for sustained release of the cannabinoid over a predetermined period of time, as well as two other delivery systems for immediate release. “While these developments add to our growing list of intellectual property, these are much more than technologies that will sit on a shelf,” Cannabis Global CEO Arman Tabatabaei said in the news release. “We have already integrated both the sustained and immediate release versions into beverage products that we expect to be available to consumers next month. We believe the field of minor and exotic cannabinoids will grow substantially this year with several product introductions. We are extremely excited at the prospect of being a first mover in this emerging market segment.”

To view the full press release, visit http://cnw.fm/7WIps

About Cannabis Global, Inc.

Cannabis Global, Inc. (MCTC) is a Nevada registered, fully reporting and audited publicly-traded company. With the hemp and cannabis industries moving very quickly and with a growing number of market entrants, Cannabis Global plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The Company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The Company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector. The company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs. For more information, visit the company’s website at www.CannabisGlobalinc.com.

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://cnw.fm/MCTC

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Announces Complete Vertical Integration of Ketamine Treatments/Therapies, Closing of AltMed Acquisition

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) continues to strengthen its vertically integrated psychedelic medicine ecosystem via the acceleration of its ketamine topicals prescription fulfillment capabilities. The company today announced the addition of central fill and compounding infrastructure for its proprietary ketamine formulations via a location at one of Canada’s leading retail pharmacy chains (the “Pharmacy”), as well as the dispensing of its products throughout the Pharmacy’s network. “With this arrangement, Champignon boasts complete vertical integration with respect to our rapid onset ketamine treatments and therapies,” Champignon CEO Gareth Birdsall stated in the news release. “From novel formulations to product development at a purpose-built GMP and DIN licensed pharmaceutical facility, and now automated prescription fulfillment and on-site compounding infrastructure, we have managed to capture the entire product lifecycle.”

In addition, Champignon announced the closing of its acquisition of AltMed Capital Corp., subject to the submission of the necessary filings to the BC Corporate Registry and including any other necessary regulatory approvals. AltMed is a Canadian ketamine clinic operator, psychedelic medicine IP aggregator and novel drug discoverer with a suite of assets that will accelerate Champignon’s multipronged business strategy. This will enable the company to reach the consumer directly through rapid-onset medical treatments, with an anticipated rollout of already identified new clinical entities (“NCEs”) to be opened across the United States and Canada.

To view the full press release, visit http://cnw.fm/2r6Sp

About Champignon Brands Inc.

Champignon Brands Inc. is a research-driven company specializing in the formulation of a suite of medicinal mushrooms health products, as well as novel ketamine, anaesthetics and adaptogenic delivery platforms for the nutritional, wellness and alternative medicine industries. Via its vertically integrated alternative medicine product range, Champignon is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (“PTSD”), as well as substance and alcohol use disorders. Under a collaborative research agreement with the University of Miami’s Miller School of Medicine, the Company is conducting pre-clinical studies and eventual human clinical trials, with the objective of demonstrating safety and efficacy of the combination of psilocybin and cannabidiol in treating mTBI with PTSD or stand-alone PTSD. Champignon continues to be inspired by sustainability, as its medicinal mushroom-infused SKUs are organic, non-GMO and vegan certified. For more information, visit the company’s website at www.Champignonbrands.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://cnw.fm/SHRM

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – New Mexico Governor Regrets Missed Opportunity to Legalize Cannabis Before COVID-19 Pandemic

One of the best arguments for legalizing cannabis has been the tax revenue states stand to earn. Aside from providing employment opportunities, a legal cannabis market can generate millions in tax revenue. And at a time like this when most businesses are shut down while the cannabis industry still soldiers on, that revenue would have been a lifesaver.

The governor of New Mexico recently said that she regretted the fact that the state hadn’t yet legalized recreational marijuana. In a press conference last week, Governor Michelle Lynn Lujan was asked how she planned to address the financial uncertainty caused by the coronavirus outbreak, and she said that although steps were being taken to handle it, she regretted losing cannabis as a source of revenue.

“If there was a time for wishful thinking, I wish we had passed recreational cannabis because that would be $100 million in tax revenue,” she says, acknowledging that the estimate was made before the outbreak.

“Nevertheless, a regulated marijuana market would be $100 million in the budget, and I’m very sad about that.”

Last year, she formed a working group to develop a legalization plan ahead of the January 2020 legislative session. The group estimated that the combined tax revenue from medical and recreational cannabis sales would be $100 annually, with sales reaching $620 million by the fifth year of legalization.

However, as the governor stated, the estimates were made before the coronavirus broke out. With most businesses shut down and stay at home orders in place, the economy is in shambles. On top of that, essential businesses like cannabis have to adhere to social distancing measures which would without a doubt affect sales. Consequently, the state would receive reduced tax revenue.

Additionally, a prior legalization bill that failed to pass stipulated that sales would begin on July 1. So even if it had been passed, the state wouldn’t have been able to collect the tax revenue.

The federal government deployed relief funds for small businesses, but since cannabis is still illegal at the federal level, marijuana businesses have been barred from accessing them. This has made it even harder for them to continue operating during the lockdown. However, a coalition of stakeholders and lawmakers are urging lawmakers to allow the state-legal cannabis industry to access the next coronavirus relief funds.

Governor Lujan had previously stated that she was open to letting voters decide on marijuana legalization through a ballot referendum. She also called for a special session but a spokesperson said that it is unlikely the reform will be pursued. Additionally, House Speaker Brian Egolf has stated that it is unlikely cannabis legalization will be part of a special session before the end of the year.

Analysts say the views expressed by Gov. Lujan show that what the cannabis industry players like Sugarmade Inc. (OTCQB: SGMD) have always said about the economic potential of marijuana is true for jurisdictions that legalize the industry.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Racial and Civil Rights Groups Urge Congress to Give Cannabis Companies Access to COVID Funds

The economic impact of the coronavirus pandemic will be felt for years to come. Early this year as parts of China shut down due to the outbreak, several industries ran into supply chain disruptions. However, as the virus spread and governments started taking more drastic measures to curb its spread, the impact was even more pronounced.

Cannabis Industry Denied Access

Most businesses are shut down and almost all commerce has ground to a halt. To help cushion small businesses and help them survive, the federal government deployed federal coronavirus relief funds through the Small Business Administration (SBA). One industry that was conspicuously denied access to those funds, however, was cannabis.

Despite being deemed essential by most states that allow cannabis, businesses in the sector cannot access these emergency relief funds. On Monday, a coalition of marijuana reform and civil rights groups sent a letter to Congressional leaders asking them to rethink this decision.

Dubbed the “Marijuana Justice Coalition (MIC),” it consists of 13 organizations including ACLU, NORML, Human Rights Watch, the Center for American Progress, and the Center for Law and Social Policy. They have asked lawmakers to make sure that future COVID-19 stimulus packages include provisions enabling the cannabis industry to receive loan and lending services through the SBA.

“Prior to the COVID-19 pandemic, the marijuana industry already struggled with inclusivity and diversity in ownership and operations, as well as countless barriers to the industry for people directly impacted by marijuana criminalization,” they said. Despite being allowed to operate during the lockdown, social distancing and delivery measures are hard on the bottom line.

The challenges caused by the coronavirus outbreak will disproportionately hit minority-owned businesses the hardest, jeopardizing efforts to make the industry more reflective of communities directly affected by marijuana prohibition, they said.

“Workers in the state-legal marijuana industry are no different from other sectors of the economy who show up to work every day to provide for their families. If marijuana businesses are unable to survive, the lives of millions of patients registered in state medical marijuana programs and the livelihoods of hundreds of thousands of marijuana workers will be under threat,” the coalition wrote.

“Until broader national reforms can be enacted, it is vital that immediate action is taken to protect small businesses, namely businesses owned and operated by people of color and people directly impacted by the war on drugs, operating in this industry. This will ensure that underrepresented business owners are able to survive this economic hit in an industry in which they are already under-resourced.”

It is widely believed that the entire cannabis industry, including companies like Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF), are hoping that the day dawns when the industry will be given equal treatment as other legitimate businesses.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Eyes Record-Breaking April Sales in Strong Structural Growth Boom

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, today announced that it has seen record total monthly cannabis sales and record sequential monthly cannabis sales growth so far in the month of April. According to the update, the company’s total gross cannabis sales for April are running at an annualized pace of more than $6 million, which is an increase of more than 400% over average monthly sales seen in calendar Q1. “This data should help to better contextualize our prior announcement detailing our expansion in total cannabis production capacity,” Cannabis Strategic Ventures CEO Simon Yu said in the news release. “Demand is through the roof. We don’t see this as a consequence of the stay-at-home policy. This is about improving market positioning in a strong structural growth boom. We are establishing a wider and wider footprint in terms of distribution partners, and the overall market is continuing to experience powerful growth in demand at the end market level.”

To view the full press release, visit http://cnw.fm/4zTzT

About Cannabis Strategic Ventures

Cannabis Strategic Ventures, Inc. (OTC: NUGS) is one of the largest publicly traded marijuana cultivators in the United States. The company is Los Angeles-based that incubates, develops and partners with category leaders within the cannabis and ancillary sectors. The firm’s NUGS brand experience provides operational and financial strategic partnerships and a range of essential services to emerging and existing cannabis consumer brands. For more information, visit www.CannabisStrategic.com.

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://cnw.fm/NUGS

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CBDNewsBreaks – Pressure BioSciences Inc. (PBIO) Inks Binding LOI to Acquire Cannaworx, Inc.

Pressure BioScience (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform-technology solutions to the worldwide life sciences and other industries, today announced that it has signed a binding letter of intent (“LOI”) to merge with Cannaworx, Inc. (USA) and its diverse portfolio of products and intellectual property. The merger will combine Cannaworx’s proprietary portfolio of consumer products with the application of PBIO’s breakthrough ultra shear technology (“UST”). Following the merge, the company will utilize its extensive intellectual property portfolio, consisting of a proprietary pressure platform, nanotechnology and advanced delivery systems, to disrupt markets including the booming U.S. hemp-derived CBD market. “We have been actively searching for an opportunity to participate in the end-product growth and upside we believe our UST platform creates and delivers. We are very excited to bring our companies together for what we believe to be a momentous inflection point in significant new growth and increased shareholder value,” PBIO president and CEO Richard T. Schumacher stated in the news release.

To view the full press release, visit http://cnw.fm/mSQ79

About Pressure BioSciences Inc.

Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life-sciences industry. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure-cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented, enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). PBIO’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the use of its recently acquired, patented technology from BaroFold Inc. (the “BaroFold” technology) to allow entry into the biopharma contract services sector, and (2) the use of its recently patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and (ii) prepare higher-quality, homogenized, extended shelf-life or room-temperature, stable, low-acid liquid foods that cannot be effectively preserved using existing nonthermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

420 with CNW – New Jersey Voters Likely to Vote in Favor of Cannabis Legalization

Last December, New Jersey lawmakers approved a resolution that would put a referendum on legalizing marijuana on the state’s 2020 ballot. A select group of lawmakers, advocates as well as Gov. Phil Murphy has been hoping to pass the marijuana legalization measure last year, but disagreements over the specifics of the bill made it impossible.

With the decision to legalize marijuana to be put on a referendum, they were hoping voters would vote in favor of legalization. “We’re optimistic that next November New Jersey voters will replace an eight-decade long policy disaster with a far more sensible approach to marijuana,” Karen O’Keefe, state policies director for the Marijuana Policy Project said at the time.

A survey by Monmouth University has found that their hopes may not be unfounded. 704 registered voters were interviewed from April 16 to 19, and a majority of them were in favor of marijuana legalization. 61% of the respondents said they would vote in support of the proposal, while 34% said they would vote against it.

On the political front, 74% of the Democrats, 74% of the independents, and 40% of the Republicans said they would vote in favor of the legalization measure in the referendum.

78% of those aged 18-34, 62% of those between 35-54 and 48% of those 55 and older supported the legalization measure. When the voters were asked about allowing individuals 21 and older to possess small amounts of cannabis, 64% were in support of it while 32% were against it.

Additionally, 48% of the New Jersey residents stated that it would be a good idea to let adults purchase cannabis from a licensed store as opposed to the black market. 38% said it was a bad idea, while 22% said they didn’t have an opinion on the matter.

“Support for the marijuana ballot measure is widespread in part because many who have no opinion on whether legalization is a good idea figure they might as well vote for it,” explains Patrick Murray, director of the Monmouth University Polling Institute.

The survey also found that six in ten New Jersey voters (62%) believe that legalizing marijuana is good for the economy. 10% say legalization will hurt the economy and 21% believe it would have no impact either way.

However, 27% of the respondents believe legalizing marijuana would lead to an increase in other drug-related crimes while 22% believe it will lead to a decrease in other drug crimes instead. 46% say legalization won’t have an effect either way.

Experts are of the view that support for the referendum may grow as campaigners get to work to marshal further support among the voters. It would be interesting to pick the brains of established companies like Round Meadow Holdings Corp. and The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) on what they think the prospects of legalization on voting day are.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.